Designing Effective Neoantigen TCR Therapy

11:00 am - Thursday 17th September 2026

  • Matching critical raw materials, characterization, and clinical response
  • Balancing production and COGS
  • Developing multi-modality approach to treat resistant cancers

Speakers:

Bob Keefe
CTO
BlueSphere Bio